| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0002 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0002 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0004 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.0007 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0009 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.001 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.16 | 0.001 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.002 |